Study of SHR-1701 Plus BP102 in Subjects With Selected Solid Tumors

Clinical trial NCT04974957 · UNKNOWN

Trial details

NCT number: NCT04974957
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer

Start date: 2021-08-30
Primary completion: 2022-02-28
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.